# Data Extraction Form: Long-Term Cardiovascular Risk After COVID-19 in Young Adults

## Study Identification
**Study ID:** [CV-COVID-YA-2025-001]
**Title:** [Full study title]
**Authors:** [Last names and initials]
**Journal:** [Journal name, volume, issue, pages]
**Publication Date:** [YYYY-MM-DD]
**DOI:** [DOI link]
**Reviewer:** [Initials/Date]

## Study Characteristics

### Study Design
- [ ] Prospective cohort
- [ ] Retrospective cohort
- [ ] Population-based registry
- [ ] Nested case-control
- [ ] Other (specify): ________________

### Study Period
- **COVID-19 Cases Period:** [Start date to end date]
- **Follow-up Period:** [Start date to end date]
- **Control Period:** [Start date to end date (if applicable)]

### Sample Size
- **Total COVID-19 Cases:** [n = ____]
- **Control Participants:** [n = ____]
- **Dropouts/Loss to Follow-up:** [n = ____ (provide reason)]
- **Final Analysis Sample:** [n = ____]

## Participant Characteristics

### COVID-19 Group
- **Age (mean ± SD):** ____ ± ____ years
- **Age Range:** ____ - ____ years
- **Sex (% Male):** ____%
- **BMI (mean ± SD):** ____ ± ____
- **Comorbidities:**
  - Diabetes: ____%
  - Hypertension: ____%
  - CHD: ____%
  - Smoking Status: ____%
- **COVID-19 Severity:** [Asymptomatic/Mild/Moderate/Severe/Critical]
- **Hospitalization Rate:** ____%
- **Variant Predominant:** [Delta/Omicron/Wild-type/Other]

### Control Group
- **Age (mean ± SD):** ____ ± ____ years
- **Age Range:** ____ - ____ years
- **Sex (% Male):** ____%
- **BMI (mean ± SD):** ____ ± ____
- **Comorbidities:**
  - Diabetes: ____%
  - Hypertension: ____%
  - CHD: ____%
  - Smoking Status: ____%
- **COVID-19 Testing:** [Yes/No/Unknown]

### Matching Variables
- [ ] Age-matched
- [ ] Sex-matched
- [ ] BMI-matched
- [ ] Comorbidity-matched
- [ ] Others (specify): ________________

## COVID-19 Diagnostic Methods
- [ ] PCR testing
- [ ] Antigen testing
- [ ] Serological testing (antibody)
- [ ] Clinical diagnosis
- [ ] Mixed methods
- [ ] Other (specify): ________________

## Follow-up Characteristics
- **Mean Follow-up Duration:** ____ months (range: ____ - ____)
- **Median Follow-up Duration:** ____ months
- **Data Sources:**
  - [ ] Electronic health records
  - [ ] National registries
  - [ ] Self-reported
  - [ ] Clinical visits
  - [ ] Other (specify): ________________

## Outcome Definitions and Measurements

### Primary Outcomes

#### 1. Myocarditis
- **Definition/Criteria:** [Clinical symptoms + biomarkers + imaging]
- **Diagnostic Method:** [ECG/cardiac MRI/endomyocardial biopsy/other]
- **Number of Events (COVID):** ____ / ____ participants
- **Number of Events (Control):** ____ / ____ participants
- **Incidence Rate (COVID):** ____ per 1,000 person-years
- **Incidence Rate (Control):** ____ per 1,000 person-years

#### 2. Cardiac Arrhythmias
- **Types Specified:** [AF/VT/VF/other arrhythmias]
- **Diagnostic Method:** [ECG/Holter monitoring/implantable device/other]
- **Number of Events (COVID):** ____ / ____ participants
- **Number of Events (Control):** ____ / ____ participants
- **Incidence Rate (COVID):** ____ per 1,000 person-years
- **Incidence Rate (Control):** ____ per 1,000 person-years

#### 3. Thromboembolic Events
- **Types Specified:** [DVT/PE/Ischemic stroke/other]
- **Diagnostic Method:** [Imaging/clinical symptoms/lab tests/other]
- **Number of Events (COVID):** ____ / ____ participants
- **Number of Events (Control):** ____ / ____ participants
- **Incidence Rate (COVID):** ____ per 1,000 person-years
- **Incidence Rate (Control):** ____ per 1,000 person-years

### Secondary Outcomes

#### Composite Cardiovascular Events
- **Definition:** [List of included outcomes]
- **Number of Events (COVID):** ____ / ____ participants
- **Number of Events (Control):** ____ / ____ participants

#### Cardiovascular Mortality
- **Number of Deaths (COVID):** ____ / ____ participants
- **Number of Deaths (Control):** ____ / ____ participants
- **Causes of Death:** [Specify]

## Risk Estimates

### Crude Estimates (if reported)
- **Myocarditis RR/OR/HR:** ____ (95% CI: ____ - ____)
- **Arrhythmias RR/OR/HR:** ____ (95% CI: ____ - ____)
- **Thromboembolism RR/OR/HR:** ____ (95% CI: ____ - ____)

### Adjusted Estimates
- **Adjustment Variables:** [List age, sex, BMI, comorbidities, etc.]
- **Myocarditis aRR/aOR/aHR:** ____ (95% CI: ____ - ____)
- **Arrhythmias aRR/aOR/aHR:** ____ (95% CI: ____ - ____)
- **Thromboembolism aRR/aOR/aHR:** ____ (95% CI: ____ - ____)

### P-values
- **Myocarditis:** ____
- **Arrhythmias:** ____
- **Thromboembolism:** ____

## Confounding and Bias Assessment

### Confounders Addressed
[List the variables that were controlled for in statistical analyses]

### Residual Confounding Assessment
- [ ] Minimal risk of confounding
- [ ] Moderate risk of confounding
- [ ] High risk of confounding
- **Reason:** ________________

### Selection Bias Assessment
- [ ] Low risk
- [ ] Moderate risk
- [ ] High risk
- **Reason:** ________________

### Information Bias Assessment
- [ ] Low risk
- [ ] Moderate risk
- [ ] High risk
- **Reason:** ________________

## Risk of Bias Assessment (Newcastle-Ottawa Scale)

### Selection (4 stars maximum)
- Representativeness of COVID group: [ ] Yes [ ] No [ ] Unclear
- Selection of Controls: [ ] Yes [ ] No [ ] Unclear
- Ascertainment of Exposure: [ ] Yes [ ] No [ ] Unclear
- Outcome not present at start: [ ] Yes [ ] No [ ] Unclear
**Selection Stars:** ____ / 4

### Comparability (2 stars maximum)
- Control for important factor: [ ] Yes: ____ [ ] No
- Control for any additional factor: [ ] Yes: ____ [ ] No
**Comparability Stars:** ____ / 2

### Outcome (3 stars maximum)
- Assessment of outcome: [ ] Yes [ ] No [ ] Unclear
- Follow-up long enough: [ ] Yes [ ] No [ ] Unclear
- Adequacy of follow-up: [ ] Yes [ ] No [ ] Unclear
**Outcome Stars:** ____ / 3

**Total NOS Score:** ____ / 9

**Overall Quality Rating:** [High/Medium/Low]

## Additional Notes
[Space for additional observations, unusual aspects, or unclear items that may need clarification]

## Extraction Verification
**First Reviewer:** [Initials/Date]
**Second Reviewer:** [Initials/Date]
**Discrepancies Resolved:** [Yes/No]
**Third Reviewer (if needed):** [Initials/Date]
